Description

Clarivate’s AI Transformation Accelerates — Web Of Science, Nexus Connect & IPOne Take Center Stage!

Clarivate’s second quarter financial results reflect a transitional period aligned with its ongoing value creation plan initiated in late 2024. The company reported revenue of $587 million for the quarter and nearly $1.2 billion for the first half of 2026. Organic annual contract value (ACV) growth improved to 1.5% year-over-year, driven by 2% growth in both the Academia & Government (A&G) and Intellectual Property (IP) segments, though the latter saw recurring revenue flat during the quarter with expectations to return to growth in the second half. Adjusted diluted earnings per share increased slightly by $0.01 to $0.19 in Q2 and 19% to $0.38 for the first half compared to last year. Clarivate’s adjusted EBITDA margin expanded to over 42%, supported by disciplined cost management and strategic portfolio rationalization, including the announced divestiture of the Life Sciences & Health (LS&H) segment.